Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.

The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...

Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.

The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...

FDA's Center for Drug Evaluation and Research director, Patrizia Cavazzoni, MD, to step down in mid-January. Other top leaders also leaving FDA.

Endpoints Weekly reports on iECURE's gene therapy success for OTC deficiency, FDA CDER director Patrizia Cavazzoni's departure, and Verdiva Bio's $411M launch with Sciwind assets.

Middle Eastcategory US, Arab mediators make some progress in Gaza talks, no deal yet, sources say January 10, 2025 Reuters, the news and media division of Thomson Reuters, is the world’s largest ...

U.S. President-elect Donald Trump will not go to jail or face any other punishment for his criminal conviction stemming from hush money paid to a porn star, a judge ruled on Friday but said Trump ...

Ukraine latest: Russian officials 'frustrated' with Putin - as Moscow responds to Trump plans to meet Kremlin leader The Kremlin has been discussing Donald Trump's claims that a meeting between ...

SC said students who dropped out between November 5 and November 18, 2024, would be permitted to register for the test.

Aurobindo Pharma stock dipped to 1,100 levels before rebounding, aligning with a channel line from October 2016’s swing high on monthly charts. The stock trades above 5, 10, 30, 50, and 200-DMA but ...

Residents in Harrow are reminded of the revised bin collection dates for this week due to the New Year holidays. For those with a usual ...